State-of-the-Art Research and New Pharmacological Perspectives on Renal Involvement in Duchenne Muscular Dystrophy: A Narrative Review. [PDF]
Bellis M +4 more
europepmc +1 more source
A Rare Co-occurrence of Duchenne Muscular Dystrophy and Glycerol Kinase Deficiency Associated With Xp21 Contiguous Gene Deletion Syndrome: A Case Report. [PDF]
Marques L +7 more
europepmc +1 more source
Delandistrogene Moxeparvovec gene therapy for Duchenne muscular dystrophy: the way forward in South Asian countries. [PDF]
Madaan P +3 more
europepmc +1 more source
Development of a cost-effectiveness analysis model for Duchenne muscular dystrophy utilizing the national registry in Japan. [PDF]
Okada T +5 more
europepmc +1 more source
Diagnostic Precision in Pediatric Neuromuscular Disorders: A Case Study of Bethlem Myopathy Mimicking Duchenne Muscular Dystrophy. [PDF]
Alyami NH +5 more
europepmc +1 more source
Correction: Use of capillary Western immunoassay (Wes) for quantification of dystrophin levels in skeletal muscle of healthy controls and individuals with Becker and Duchenne muscular dystrophy. [PDF]
Beekman C +4 more
europepmc +1 more source
Advancing cardiac monitoring in adult Duchenne muscular dystrophy: longitudinal insights and real-world challenges. [PDF]
Tabary M, Wehrens XHT.
europepmc +1 more source
Duchenne Muscular Dystrophy in the Republic of North Ossetia-Alania: Epidemiological Study, Diagnostic Issues, and Treatment Prospects. [PDF]
Zinchenko R +15 more
europepmc +1 more source
Exploring the evidence for the use of protein biomarkers of muscular damage and disease progression in Duchenne and Becker muscular dystrophy: a systematic review and meta-analysis protocol. [PDF]
Mondello S +7 more
europepmc +1 more source
Correction: The rise of rat models for Duchenne muscular dystrophy and therapeutic evaluations. [PDF]
Relaix F +3 more
europepmc +1 more source

